Clinical and epidemiological data were collected from 187 clinically diagnosed measles patients in Haj Yousif area, suburban Khartoum. Laboratory tests confirmed the diagnosis in 141 (75%) of the cases, but demonstrated that in 46 (25%) patients the clinical symptoms were not caused by an acute measles virus (MV) infection. According to their vaccination card, 59% of the laboratory-confirmed measles cases had been vaccinated for measles. Compared with non-measles rash disease cases, confirmed measles cases more often had severe illness (P < 0.0001), were dehydrated (P ¼ 0.01) at presentation and less likely to recover without complications [OR 0.19 (95% CI 0.09, 0.39)]. There was no difference in death rate (P ¼ 0.20). Underweight [weight-for-age Z score (WAZ) £ )2 SD] was an independent predictor of recovery with complications [OR 0.4 (95% CI 0.2, 0.99)]. Severe measles cases (those who developed diarrhoea, pneumonia, otitis media, encephalitis or haemorrhagic rash) had similar vaccination rates and time intervals since vaccination as uncomplicated measles cases. Although severe measles had lower WAZ-scores (P ¼ 0.004), none of the nutritional parameters studied were predictive of outcome. Mortality was higher in the severe measles group [OR 8.8 (95% CI 1.7, 85.2)]. In 11 of 141 confirmed measles cases serological evidence of a recent infection with another virus was found, most commonly varicella zoster virus and dengue virus; spotted fever and rubella were among the most frequent diagnoses in 17 of 47 cases of the non-measles cases.
Introduction
Measles is a major cause of morbidity and mortality in children, in particular in developing countries; it is estimated by the World Health Organization (WHO) that in 1997 it killed one million children (WHO 1998) . Although the introduction of live attenuated measles virus (MV) vaccines has successfully interrupted circulation of wild type MV in most developed countries, in large parts of Africa and Asia vaccination efforts have been less successful, Sudan being no exception.
Measles is the most common diagnosis among immunizable diseases in febrile children who present at the emergency hospitals in Khartoum. The Expanded Programme for Immunization (EPI) estimated that measles vaccination coverage in Sudan is about 63% (UNICEF 2000) . Recently, an epidemic of measles occurred in Gedaref state despite regular coverage by EPI (E.E. Zijlstra, personal observation). The WHO developed a standard clinical case definition as part of strategies aiming at the prevention of periodic measles outbreaks: 'Any person with: generalized maculopapular rash (i.e. non-vesicular) and history of fever of 38°C (101°F) or more (if not measured, ''hot'' to touch) and at least one of the following: cough, coryza or conjunctivitis (i.e. red eyes); or any person in whom a health professional suspects measles' (WHO 1996) . Similarly, in strategies aiming at elimination of measles in certain areas, this case definition is used to identify suspected measles cases that will subsequently be laboratory-confirmed. The accuracy of this case definition is limited as other (viral) infections may present with similar clinical features, and conversely, measles may present atypically, especially in immunocompromised patients or in individuals with waning MV-specific immunity.
We conducted a measles cohort study in which clinical and epidemiological data were collected from clinically diagnosed measles patients (De Swart et al. 2001a) . We previously reported the use of clinical specimens from this study to develop new methods for laboratory diagnosis on the basis of plasma and throat swab samples (El Mubarak et al. 2000) or filter paper blood samples (De Swart et al. 2001b) . Here, we report the epidemiological and clinical characteristics of this cohort, as well as the acute and delayed impact of measles infection in children in a suburban community in Khartoum.
Patients and methods
The study was conducted between March 1997 and July 1999 in Haj Yousif (estimated population size 500 000), a large residential area in suburban Khartoum. The inhabitants are mainly displaced people from southern and western Sudan who live in the area on a semi-permanent basis. Health care is provided by health centres mainly run by non-governmental organizations and two small government hospitals. Measles vaccination coverage is low, and measles cases occur throughout the year.
We actively sought for measles cases through regular house visits (2-3 per week) by interviewers. These were health-trained personnel living in the area. They work voluntarily or as part-time vaccinators, surveyors, nutritionists or laboratory technicians. They were informed about the objectives of the study and the WHO criteria of diagnosing clinical measles. The research team (composed of a paediatrician, two postgraduate students and a medical officer) visited the health centres twice weekly to see cases identified by the interviewers, and patients in health centres reported by the clinicians as having measles. If a patient with measles failed to report, a house visit was made. Any suspected measles patient was then seen and examined by the research team. If the patient was found to meet the WHO standard clinical case definition for measles (WHO 1996) , informed consent was obtained from the parent or legal guardian for participation in the study. A typed questionnaire was then completed, which included a number of questions pertaining to the socio-economic status of the patient: income, education of the mother and the father, occupation of the father, type of house and access to piped water, latrines and electricity. A physical examination was conducted, which included measurement of weight and height. All patients were given vitamin A, and any complication encountered was treated when possible.
A number of cases needed hospital care and were admitted to Khartoum Children's Emergency Hospital.
Patients were classified as having severe measles when they developed complications (diarrhoea, pneumonia, otitis media, encephalitis or haemorrhagic rash) that necessitated hospitalization; otherwise they were labelled as uncomplicated measles.
To allow comparison between severe measles patients, uncomplicated measles patients and non-measles rash disease patients, we included hospital cases of severe measles, some of whom were outside the cohort.
Patients' vaccination status for DTP, polio, BCG and measles was assessed by information from the mother and by inspection of a vaccination card when available. Clinical specimens collected included a throat swab and a blood sample. The laboratory diagnosis of measles was based on measurement of MV-specific serum immunoglobulin M (IgM) antibodies using two different assay systems [an in-house IgM capture enzyme-linked immunosorbent assay (ELISA) and a fluorescence-activated cell scanner (FACS)-measured immunofluorescence assay]. For patients with low MV-specific IgM responses, an MVspecific virus neutralization assay was performed and a reverse transcriptase-polymerase chain reaction test was carried out on throat swab samples to achieve a final diagnosis as described previously (El Mubarak et al. 2000) . All serum samples were also tested for IgM antibodies specific for a number of other infectious agents known to cause 'measles-like' clinical symptoms using commercially available assays. These included assays for IgM antibodies to rubella (capture ELISA, Organon Teknika, Boxtel, the Netherlands); dengue virus (capture ELISA, MRL Diagnostics, Cypress CA, USA); parvovirus B19 (capture ELISA, Biotrin International, Dublin, Ireland); varicella zoster virus (capture ELISA, Enzy-Well, Italy), human herpes virus 6 (indirect ELISA, PanBio, East Brisbane, Australia; confirmation of positive samples by immunofluorescence); Epstein-Barr virus (indirect ELISA, Gull laboratories, Salt Lake City, UT, USA); Rickettsia conorii (immunofluorescence, PanBio INDX, Baltimore, MD, USA); R. prowazekii (immunofluorescence PanBio INDX, Baltimore, MD, USA); mycoplasma (immunofluorescence, PanBio INDX, Baltimore, MD, USA); sandfly fever (capture ELISA, in-house assay) and Chikungunya virus (capture ELISA, in-house assay).
Follow-up visits were conducted by the research team 2 weeks after the first visit, to note acute sequelae of measles (defined as complications, death or recovery with/ without complications). Monthly follow-up visits continued for 12 months to monitor the delayed effects of measles.
Statistical analysis
After entry in Epi-Info, data were analysed further by SPSS. Differences between laboratory-confirmed measles cases and non-measles rash disease cases, as well as between severe measles and uncomplicated measles cases in age and sex distribution, previous vaccination, clinical features, nutritional parameters, state of dehydration, severity of measles, and presence of concurrent infection were tested by chi-square test (with Yates' continuity correction), Fisher's exact test or t-test where appropriate. Numerical data that did not have a normal distribution were analysed by the Kruskal-Wallis test. Using logistic regression, odds ratios with 95% confidence intervals were calculated for three categories of outcome (recovered without complications, recovered with complications and death).
From the recorded weight and height Z-scores [weightfor-height (WHZ) as measure for wasting, weight-for-age (WAZ) as measure for underweight and height-for-age (HAZ) as measure for stunting] were calculated using Epi-Info. Pearson's correlation coefficient was calculated to demonstrate a correlation between any of these nutritional parameters and the diagnosis of measles or nonmeasles, as well as to test a correlation with severe or uncomplicated measles. Logistic regression was used to explore a correlation between any of the nutritional parameters and outcome. This was first done for the whole range of Z-scores. Secondly, we explored whether children who had severe wasting (as indicator of recent weight loss: WHZ £ )2 SD) on top of severe stunting (as indicator of long-term malnutrition: HAZ £ )2 SD) were more at risk of developing complications than those who did not have this combination of parameters.
The study was approved by the Ethical Committee of the University of Khartoum.
Results
Clinical and epidemiological data were collected from 187 clinically diagnosed measles patients. Laboratory diagnosis confirmed the diagnosis in 141 (75%); these were called 'laboratory-confirmed measles cases'. In 46 (25%) of the patients the clinical symptoms were not caused by an acute MV infection and they were classified as 'non-measles rash disease patients'. A comparison of descriptive and clinical features of the two groups is given in Table 1 .
Of the 141 laboratory-confirmed measles cases, 18 (13%) were £ 9 months of age (the age at which vaccination is normally administered). Laboratory-confirmed measles cases had a lower median age, although this was not statistically significant (Kruskal-Wallis test: P ¼ 0.20); no differences were found in sex distribution between the two groups. An absent history of vaccination for measles was significantly more common in the confirmed measles cases. However, in 61 patients of whom a vaccination card was available for inspection, 59% of the laboratoryconfirmed measles patients had been vaccinated for measles; for non-measles cases this was 70% (v 2 ¼ 0.75; P ¼ 0.39). There was no difference in risk of death between those who had been vaccinated for measles and those who had not (P ¼ 0.32, Fishers's exact test). The vaccination status for measles was considerably lower than for other immunizable diseases (DTP 1, 2, 3; polio 1, 2, 3 and BCG), for which the coverage was over 90%.
Clinically, there was no difference in the prevalence of coryza, cough or conjunctivitis between the two groups, but laboratory-confirmed measles cases more often had severe illness and were more often dehydrated at presentation. They also tended to have more frequent combinations of concurrent infections, in particular pneumonia and gastro-enteritis, although this was not statistically significant. Measles cases were significantly less likely to recover without complications [OR 0.19 (95% CI 0.09, 0.39)], although there was no difference in risk of death [OR 3.9 (0.5, 31.7) ] between measles and non-measles cases.
We explored whether being underweight, wasted or stunted at the time of presentation were correlated with either diagnosis or with outcome by calculating the relevant Z-scores (WAZ, WHZ and HAZ, respectively). There was no difference between laboratory-confirmed measles cases or non-measles rash disease cases with regard to WHZ score (P ¼ 0.90) and WAZ score (P ¼ 0.13). However, measles cases had a higher HAZ score than nonmeasles cases (P ¼ 0.02). Using logistic regression, we explored the relation between the nutritional variables as independent variables and outcome (recovery with complications or not) as dependent variable for both groups. None of the parameters WHZ, WAZ or HAZ was found to predict outcome [OR 0.8 (0.3, 2 .1), OR 2.0 (0.5, 8.1) and OR 0.8 (0.3, 1.7), respectively], but further analysis showed that WAZ £ )2 SD was an independent predictor of recovery with complications [OR 0.4 (0.2, 0.99)], whereas this was not so for those with WHZ £ )2 SD [OR 1.3 (0.6, 2.9)] and HAZ £ )2 SD [OR 1.3 (0.6, 2.7)].
Patients who were classified as severe measles cases had a similar age and sex distribution as uncomplicated measles cases (Table 2 ). There was no difference in measles vaccination status and time interval since vaccination. Severe measles cases were more often found to be dehydrated. Although the number of patients with infective complications tended to be higher in the severe measles group, this did not reach statistical significance. Patients with severe measles tended to have lower HAZ scores than uncomplicated measles cases, although this was not statistically significant (r ¼ )0.20; P ¼ 0.06). Severe measles had a significantly lower WAZ (P ¼ 0.004), but not WHZ (P ¼ 0.25). None of the three parameters was predictive of outcome. In uncomplicated measles there was no mortality in the first months; in those who could be followed-up, there was one death after 2 months (1/50 ¼ 2%). In severe measles, mortality was highest in the first month (9/41 ¼ 22%); in those who were followed-up another two deaths occurred after 2 months resulting in an overall mortality after 1 year of 11/41 (27%), which is a significantly higher mortality rate than that observed in uncomplicated measles cases [OR 8.8 (95% CI 1.7, 85.2)]. During the whole period of follow-up to 12 months, severe measles cases continued to have more complications, initially, of episodes of gastroenteritis and later, of respiratory tract infections. Uncomplicated measles cases did not differ from non-measles cases with regard to their clinical status at all time points (Table 3) .
In 11 of 141 laboratory-confirmed measles cases we found evidence of recent infection with another pathogen; in the non-measles cases, 17 of 47 cases had IgM antibodies to pathogens known to cause measles-like clinical symptoms, of which rubella and spotted fever (R. conorii) were the most frequent (Table 4) .
Discussion
The WHO standard clinical cases definition was designed for maximum sensitivity at the expense of specificity for surveillance purposes and led to a correct diagnosis in 75% of measles cases in our field study population. Reports from other areas vary: in Zambia, a higher sensitivity of 86% (increasing to 100% after 4 days) was found among hospitalized children, who may have been more ill and therefore more likely to have measles than another viral illness which on average, as also observed in this study, runs a milder course (Oshitani et al. 1997 ). An Australian study used notification to a public health unit as the entry criterion and found only 49% sensitivity using the slightly different CDC classification, which is identical to the WHO definition apart from requiring the fever to be >38.3°C and the rash to be present for at least 3 days (CDC 1990; Ferson et al. 1995) . As expected, the positive predictive value decreased even further as the prevalence of measles decreased (Lambert et al. 2000) . We found no differences between laboratory-confirmed measles cases and non-measles rash disease cases in any of the clinical criteria of the WHO case definition, and it is unlikely that adapted sets of criteria will perform significantly better. We were able to diagnose some of the non-measles cases, and a variety of other (viral) infections was found to be circulating in the area. This study does not allow to estimate the importance of these other infections, as no controls without a rash were tested; similarly the proportion of non-measles rash disease may vary with the vaccination coverage for measles and therefore the expected number of cases of measles. Rickettsial infection Table 3 Complications in severe measles, uncomplicated measles and non-measles rash disease cases after 1, 6 and 12 month follow-up and rubella were the most common. Rubella may be misdiagnosed as measles (Ferson et al. 1995) . Also arboviral infections were detected; arboviruses were among pathogens held responsible for an outbreak of febrile illness in 1988, and are most likely endemic in the Northern Province of Sudan (Watts et al. 1994; McCarthy et al. 1996) . Some of these viral illnesses may present with similar clinical features as measles, as shown in a study from Somalia among febrile patients with or without a rash (Nur et al. 1999) . In 8% of laboratory-confirmed measles cases, evidence was found for recent infection with another pathogen. It should be noted, however, that simultaneous IgM reactivity against more than one virus may occur (Thomas et al. 1999) . Only our measles cases were diagnosed by a combination of different assays; this was not carried out for the other diagnoses. The median age of measles cases (24 months) was higher than expected in a developing country setting, where measles usually occurs at a younger age than in developed countries. Thirteen per cent of measles affected children were aged <9 months, which is the age at which EPI normally administers measles vaccination. At 62%, the vaccination status for measles was low, especially compared with DTP, polio and BCG (coverage > 90%). The median age of measles cases tended to be lower than that of non-measles cases (median age 38 months), but this did not reach statistical significance.
Of all socio-economic indicators, only the father's education was significantly associated with the presence of a vaccination card (data not shown). Given the discrepancy between measles vaccination rates and rates for other vaccinations, it may be assumed that the logistics of measles vaccine delivery is the limiting event in those who bring their children to the health centre for vaccination. The high percentage of confirmed measles cases who had been vaccinated against measles raises concerns about vaccination efficacy. This is in contrast with findings from developed countries with reliable vaccine delivery, where clinical measles is unlikely in MMR vaccinees, and other diagnoses should be considered (Davidkin et al. 1998) .
Clinically, the measles cases differed from the nonmeasles cases in that they were more severely ill, more often dehydrated at presentation and more commonly developed combinations of infections. They were also less likely to recover without complications (mainly pneumonia and gastro-enteritis) for which being underweight could be a contributing factor. However, there was no difference in mortality between measles and non-measles cases. Similar observations were previously reported from hospital cases in Khartoum Children's Emergency Hospital (Hussain et al. 1989 ).
More than 50% of all measles cases were clinically considered severe measles, as defined by the development of complications. The development of severe measles could not be explained by differences in vaccination history for measles or time interval since vaccination. Possibly, stunted children might be more at risk for severe measles as lower height-for-age scores were found as compared with uncomplicated measles, although this difference did not reach significance (P ¼ 0.06). The prevalence of HIV infection in the study area as well as among our patients is unknown, but clinical experience does not suggest that HIV infection is a major contributing factor to morbidity in the study population. Severe measles cases had lower WAZ than uncomplicated measles cases, which may be the result of the current illness or pre-existing underweight. Severe measles cases were at higher risk of dying, but none of the clinical parameters tested (age, sex, measles vaccination status, time since measles vaccination and nutritional parameters) were found to predict this outcome (data not shown). Mortality was highest in the first month of illness; in the severe measles group, nine infants died in the first month and two in the second month after onset of clinical symptoms. Follow-up was incomplete in particular for the severe measles cases, as some of them came from places outside the study area; therefore, the mortality rate may be underestimated. However, the inclusion of some hospital cases in our cohort may have resulted in an overestimation of the frequency of severe measles. In those who could be followed-up, the severe measles cases appeared to have more complications after discharge than the uncomplicated measles cases. Both groups of measles cases continued to have more complications than the non-measles cases even after 12 months. These differences may be explained by incomplete recovery from the measles episode, the nutritional abnormalities (pre-existing or induced by measles), prolonged infection possibly causing immunosuppression, or other factors. The extent to which each of these patient groups developed (persisting) abnormal immune responses is currently the subject of a study.
This study shows that measles is common in suburban Khartoum, despite reported high vaccination coverage by EPI. The mortality of 11% caused by measles (27% in severe measles) in this endemic area in the suburbs of the capital is unacceptably high. As only 6% of cases were below the age of 9 months, the age at which they should have received vaccination, the majority of cases and deaths should have been prevented by vaccination. If measles is to be eliminated in the Sudan in the near future, more adequate vaccine delivery would be required, as well as an evaluation of vaccination efficacy. In addition, further epidemiological studies are needed to measure the impact of and refine current strategies, and there is a great need for a cheap, rapid field test with high sensitivity and specificity.
